SUPREMA INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 24,700 KRW | +2.28% |
|
-4.45% | +18.47% |
| Mar. 22 | Tranche Update on Suprema Inc.'s Equity Buyback Plan announced on March 21, 2023. | CI |
| Mar. 22 | Tranche Update on Suprema Inc.'s Equity Buyback Plan announced on March 21, 2023. | CI |
| Sales 2024 * | 109B 78.45M | Sales 2025 * | 124B 89.28M | Capitalization | 170B 123M |
|---|---|---|---|---|---|
| Net income 2024 * | 25B 18.05M | Net income 2025 * | 28B 20.22M | EV / Sales 2024 * | 0.75 x |
| Net cash position 2024 * | 89.4B 64.55M | Net cash position 2025 * | 102B 73.9M | EV / Sales 2025 * | 0.55 x |
| P/E ratio 2024 * |
6.76
x | P/E ratio 2025 * |
6.06
x | Employees | 206 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 62.08% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +2.28% | ||
| 1 week | -4.45% | ||
| 1 month | +2.07% | ||
| 3 months | +1.02% | ||
| 6 months | +19.32% | ||
| Current year | +18.47% |
1 week
23 900.00
26 150.00
1 month
23 900.0027 450.00
Current year
20 250.0029 150.00
1 year
19 020.0029 150.00
3 years
19 020.0030 300.00
5 years
19 020.0048 000.00
10 years
15 200.0048 000.00
| Managers | Title | Age | Since |
|---|---|---|---|
Han-Chul Kim
CEO | Chief Executive Officer | 54 | - |
Jae-Won Lee
CEO | Chief Executive Officer | 55 | - |
Hee-Su Yang
DFI | Director of Finance/CFO | 56 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jae-Won Lee
CEO | Chief Executive Officer | 55 | - |
Bong-Seob Song
CTO | Chief Tech/Sci/R&D Officer | 54 | - |
Hee-Su Yang
DFI | Director of Finance/CFO | 56 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-31 | 24,700 | +2.28% | 42,105 |
| 24-05-30 | 24,150 | -1.43% | 72,059 |
| 24-05-29 | 24,500 | -3.54% | 57,299 |
| 24-05-28 | 25,400 | -0.59% | 80,840 |
| 24-05-27 | 25,550 | -1.16% | 51,624 |
End-of-day quote Korea S.E., May 30, 2024
More quotes
Suprema Inc. is a Korea-based company engaged in the biometrics business. The Companyâs offerings consist of fingerprint systems and fingerprint solutions. Its fingerprint systems include Internet protocol (IP)-based access control and time attendance terminals under the brand names of BioStation, D-Station, FaceStation, BioEntry, BioLite and others. Its fingerprint solutions are used in its related fingerprint systems. The Company distributes its products within domestic market and to overseas markets.
Sector
Electronic Equipment & Parts
Calendar
2024-08-13
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
24,700
KRW
Average target price
40,000
KRW
Spread / Average Target
+61.94%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +18.47% | 123M | |
| -27.70% | 1.5B | |
| +130.65% | 131M | |
| +14.93% | 81.26M |
- Stock Market
- Equities
- A236200 Stock
